Yang et al. [20] showed a loss of overall Syk mRNA expression in half of CRC patients due to the hypermethylation of the Syk promoter region, which was associated with a higher tumor stage and reduced five-year overall survival in a heterogeneous group of stage I-IV colon and rectum carcinoma. The gene discussed is SYK; the disease is neoplasm.